GP-Act III Acquisition (GPAT) Shares Outstanding (2023 - 2025)

GP-Act III Acquisition has disclosed Shares Outstanding across 3 years of filings, most recently posting $7.2 million for Q4 2025.

• Quarterly Shares Outstanding changed 0.0% year-over-year to $7.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $7.2 million, changed 0.0% from the prior year.
• Shares Outstanding was little changed at $7.2 million in Q4 2025, from $7.2 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $7.2 million in Q1 2023 and troughed at $7.2 million in Q1 2023.
• A 3-year average of $7.2 million and a median of $7.2 million in 2023 frame the typical range for Shares Outstanding.
• Biggest YoY gain for Shares Outstanding was 0.0% in 2024; the steepest drop was 0.0% in 2024.
• Tracing GPAT's Shares Outstanding over 3 years: stood at $7.2 million in 2023, then changed by 0.0% to $7.2 million in 2024, then changed by 0.0% to $7.2 million in 2025.
• Business Quant data shows GPAT's Shares Outstanding at $7.2 million in Q4 2025, $7.2 million in Q3 2025, and $7.2 million in Q2 2025.